TELA BIO INC. - COMMON STOCK

TELA Bio Secures Up to $50 Million in Debt Financing from MidCap Financial

31 May 2022 06:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Jefferies Healthcare Conference

26 May 2022 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Reports First Quarter 2022 Financial Results

10 May 2022 15:01:01 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conference

09 May 2022 06:00:01 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 Apr 2022 16:00:00 By Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2022 Financial Results

26 Apr 2022 06:00:01 By Nasdaq GlobeNewswire

TELA Bio Appoints D. Taylor Ocasio as General Counsel

18 Apr 2022 06:00:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Conference

30 Mar 2022 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Reports Fourth Quarter and Full Year 2021 Financial Results

21 Mar 2022 15:01:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Canaccord Genuity Musculoskeletal Conference in Chicago, IL

16 Mar 2022 06:00:01 By Nasdaq GlobeNewswire

TELA Bio to Announce Fourth Quarter and Full Year 2021 Financial Results

07 Mar 2022 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of SiteGuard™ No Rinse Antimicrobial Solution

03 Mar 2022 06:00:01 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25 Feb 2022 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Reports Strong Third Quarter 2021 Revenues Reflecting Continued Growth Driven by Increased Demand

10 Nov 2021 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces Publication of 12-Month Results from the BRAVO Study with Continued Positive Outcomes Through 24 months

09 Nov 2021 06:00:03 By Nasdaq GlobeNewswire

TELA Bio to Participate in Three Upcoming Conferences

08 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

TELA Bio and Next Science Enter into Exclusive Distribution Agreement in the Plastic Reconstructive Market for Advanced Anti-Biofilm Surgical Wash

01 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2021 Financial Results

27 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer

27 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

TELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique

13 Sep 2021 06:00:01 By Nasdaq GlobeNewswire